Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (Duchenne), Friedreich’s ataxia (FA), catecholaminergic polymorphic ventricular tachycardia (CPVT), TNNT2-mediated dilated cardiomyopathy, BAG3-mediated dilated cardiomyopathy, and additional fatal, genetic cardiac diseases. We are advancing a diverse pipeline and delivery platform in the pursuit of uniting experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted by Duchenne, Solid’s mission is to improve the daily lives of patients living with devastating rare diseases. Solid Biosciences is seeking a Vice President of Managed Markets to lead the development and execution of the company’s comprehensive U.S. and Global market access strategy. This individual will play a key leadership role in preparing for and supporting product launch by ensuring broad, sustainable access to therapies through effective payer strategies, pricing and contracting frameworks, field access deployment, and integrated patient support solutions. This role will also be responsible for leading HEOR planning and evidence generation to support the value proposition of Solid Biosciences’ therapies. The successful candidate will bring deep experience in market access, a strategic mindset, and a collaborative approach to working across Medical Affairs, Commercial, and external stakeholders.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Number of Employees
51-100 employees